PRESS RELEASE published on 10/21/2025 at 18:49, 11 months 3 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce une validation historique dans la revue NATURE confirmant la causalité génétique de l'apolipoprotéine A-I (ApoA-I) dans le sepsis. Une avancée majeure dans le traitement de la septicémie Validation Historique ABIONYX Pharma Nature Septicémie Causalité Génétique
PRESS RELEASE published on 10/21/2025 at 18:49, 11 months 3 days ago Inside Information / Other news releases ABIONYX Pharma announces groundbreaking genetic validation study published in NATURE confirming Apolipoprotein A-I (ApoA-I) causality in Sepsis, reshaping critical care medicine ABIONYX Pharma Sepsis Genetic Validation Study NATURE Publication Apolipoprotein A-I
BRIEF published on 10/06/2025 at 15:00, 11 months 18 days ago Franchissement de seuil par la Caisse des dépôts et consignations dans ABIONYX PHARMA Droits De Vote Franchissement De Seuil CDC Bpifrance ABIONYX
BRIEF published on 10/06/2025 at 15:00, 11 months 18 days ago Threshold crossing by the Caisse des dépôts et consignations in ABIONYX PHARMA Voting Rights CDC Threshold Crossing Bpifrance ABIONYX
BRIEF published on 10/06/2025 at 14:56, 11 months 18 days ago Franchissement de Seuil par Bpifrance chez ABIONYX PHARMA Droits De Vote Franchissement De Seuil Actions Bpifrance ABIONYX Pharma
BRIEF published on 10/06/2025 at 14:56, 11 months 18 days ago Threshold Crossing by Bpifrance at ABIONYX PHARMA Voting Rights Actions Threshold Crossing Bpifrance ABIONYX Pharma
PRESS RELEASE published on 10/06/2025 at 14:55, 11 months 18 days ago Franchissement de seuil Déclaration de franchissement de seuil pour ABIONYX PHARMA par la Caisse des dépôts et consignations via Bpifrance Participations Déclaration Franchissement De Seuil Bpifrance Caisse Des Dépôts ABIONYX Pharma
PRESS RELEASE published on 10/06/2025 at 14:51, 11 months 18 days ago Franchissement de seuil Déclaration de franchissement de seuil par Bpifrance concernant ABIONYX PHARMA sur Euronext Paris, le 29 septembre 2025 Euronext Paris Franchissement De Seuil Bpifrance ABIONYX Pharma 29 Septembre 2025
BRIEF published on 09/25/2025 at 20:21, 11 months 29 days ago ABIONYX Pharma : Résultats financiers du premier semestre 2025 Résultats Financiers Recherche Et Développement Trésorerie Plan France 2030 ABIONYX Pharma
BRIEF published on 09/25/2025 at 20:21, 11 months 29 days ago ABIONYX Pharma: Financial results for the first half of 2025 Financial Results Research And Development Treasury France 2030 Plan ABIONYX Pharma
Published on 09/25/2026 at 07:30, 5 hours 2 minutes ago Tocvan Reports Positive Closed-Circuit Column Leach Results at Gran Pilar
Published on 09/25/2026 at 00:30, 12 hours 2 minutes ago Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Published on 09/25/2026 at 00:15, 12 hours 17 minutes ago CoTec Holdings Corp. Announces Extension of Private Placement of Unsecured Convertible Debentures
Published on 09/24/2026 at 22:01, 14 hours 31 minutes ago Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/25/2026 at 12:26, 5 minutes ago VitrA Tiles Introduces "The Code" concept and the New Codes of Design at Cersaie Fair
Published on 09/25/2026 at 10:00, 2 hours 32 minutes ago AI and supply chains open new pathways to systemic stress as risks become more interconnected, find Swiss Re Institute and LSE
Published on 09/25/2026 at 09:09, 3 hours 23 minutes ago flatexDEGIRO sets course for next phase of growth
Published on 09/25/2026 at 07:00, 5 hours 32 minutes ago ENGIE mobilise une aide exceptionnelle de 54 millions d'euros pour soutenir les ménages les plus fragiles face à la hausse des prix de l'énergie
Published on 09/24/2026 at 18:31, 18 hours ago LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:00, 18 hours 32 minutes ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 18 hours 32 minutes ago GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
